Carmen Stanca

1.8k total citations
17 papers, 728 citations indexed

About

Carmen Stanca is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Carmen Stanca has authored 17 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 12 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Carmen Stanca's work include Liver Disease Diagnosis and Treatment (12 papers), Liver Diseases and Immunity (11 papers) and Liver Disease and Transplantation (7 papers). Carmen Stanca is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Liver Diseases and Immunity (11 papers) and Liver Disease and Transplantation (7 papers). Carmen Stanca collaborates with scholars based in United States, United Kingdom and Australia. Carmen Stanca's co-authors include Thomas D. Schiano, Nancy Bach, Joseph A. Odin, Andrea D. Branch, Maria Isabel Fiel, Aftab Ala, Scott L. Friedman, Carol Bodian, Jarone Lee and Adam Belanger and has published in prestigious journals such as Hepatology, The American Journal of Gastroenterology and Transplantation.

In The Last Decade

Carmen Stanca

17 papers receiving 717 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carmen Stanca United States 13 559 475 274 101 48 17 728
Lia Bellis Italy 13 400 0.7× 328 0.7× 178 0.6× 65 0.6× 38 0.8× 31 582
Mical S. Campbell United States 17 678 1.2× 529 1.1× 375 1.4× 39 0.4× 21 0.4× 27 896
Luc Lasser Belgium 9 531 0.9× 385 0.8× 316 1.2× 34 0.3× 37 0.8× 21 737
Haldun Selçuk Türkiye 14 172 0.3× 207 0.4× 217 0.8× 93 0.9× 26 0.5× 55 477
James D. Eason United States 14 271 0.5× 228 0.5× 236 0.9× 44 0.4× 11 0.2× 45 568
Giovanni Perricone Italy 15 778 1.4× 736 1.5× 317 1.2× 33 0.3× 77 1.6× 53 1.1k
Maria Mela United Kingdom 13 371 0.7× 312 0.7× 208 0.8× 32 0.3× 32 0.7× 27 583
Anil B. Seetharam United States 16 386 0.7× 337 0.7× 298 1.1× 61 0.6× 20 0.4× 46 658
Nae‐Yun Heo South Korea 16 382 0.7× 407 0.9× 197 0.7× 257 2.5× 37 0.8× 54 864
Greg Everson United States 13 558 1.0× 347 0.7× 361 1.3× 70 0.7× 39 0.8× 23 740

Countries citing papers authored by Carmen Stanca

Since Specialization
Citations

This map shows the geographic impact of Carmen Stanca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Stanca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Stanca more than expected).

Fields of papers citing papers by Carmen Stanca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen Stanca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Stanca. The network helps show where Carmen Stanca may publish in the future.

Co-authorship network of co-authors of Carmen Stanca

This figure shows the co-authorship network connecting the top 25 collaborators of Carmen Stanca. A scholar is included among the top collaborators of Carmen Stanca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen Stanca. Carmen Stanca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Olsen, Sonja K., David Feldman, James Park, et al.. (2021). Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications. The American Journal of Gastroenterology. 116(7). 1414–1425. 79 indexed citations
2.
Stanca, Carmen, Costica Aloman, Maria Isabel Fiel, et al.. (2015). The dynamic and clinical significance of autoantibodies and immunoglobulins in liver transplant recipients. Clinical Transplantation. 30(3). 241–246. 4 indexed citations
3.
Singal, Ashwani K., Carmen Stanca, Virginia Clark, et al.. (2011). Natural history of small duct primary sclerosing cholangitis: a case series with review of the literature. Hepatology International. 5(3). 808–813. 21 indexed citations
4.
Stanca, Carmen, Maria Isabel Fiel, Louis M. Aledort, et al.. (2010). Factors Associated With Persistent Thrombocytopenia after Liver Transplantation. Transplantation Proceedings. 42(5). 1769–1773. 9 indexed citations
5.
Stanca, Carmen, et al.. (2009). Intranasal Desmopressin Versus Blood Transfusion in Cirrhotic Patients With Coagulopathy Undergoing Dental Extraction: A Randomized Controlled Trial. Journal of Oral and Maxillofacial Surgery. 68(1). 138–143. 41 indexed citations
6.
Hytiroglou, Prodromos, Julio Gutiérrez, M. Freni, et al.. (2009). Recurrence of primary biliary cirrhosis and development of autoimmune hepatitis after liver transplant: A blind histologic study. Hepatology Research. 39(6). 577–584. 10 indexed citations
7.
Stanca, Carmen, et al.. (2008). Pathogenic Role of Environmental Toxins in Immune-Mediated Liver Diseases. Journal of Immunotoxicology. 5(1). 59–68. 15 indexed citations
8.
Stanca, Carmen, Nancy Bach, Jorge Allina, et al.. (2008). Atorvastatin Does Not Improve Liver Biochemistries or Mayo Risk Score in Primary Biliary Cirrhosis. Digestive Diseases and Sciences. 53(7). 1988–1993. 21 indexed citations
10.
Lee, Jarone, Adam Belanger, John T. Doucette, et al.. (2007). Transplantation Trends in Primary Biliary Cirrhosis. Clinical Gastroenterology and Hepatology. 5(11). 1313–1315. 99 indexed citations
11.
Stanca, Carmen, Maria Isabel Fiel, Nickolas Kontorinis, et al.. (2007). Chronic Ductopenic Rejection in Patients With Recurrent Hepatitis C Virus Treated With Pegylated Interferon Alfa-2a and Ribavirin. Transplantation. 84(2). 180–186. 36 indexed citations
12.
Allina, Jorge, Carmen Stanca, John J. Garber, et al.. (2007). Anti-CD16 autoantibodies and delayed phagocytosis of apoptotic cells in primary biliary cirrhosis. Journal of Autoimmunity. 30(4). 238–245. 28 indexed citations
13.
Stanca, Carmen, Maria Isabel Fiel, & Thomas D. Schiano. (2006). Exacerbation of Sickle Cell Disease Itself as a Cause of Abnormal Liver Chemistry Tests. Digestive Diseases and Sciences. 52(1). 176–178. 3 indexed citations
14.
Ala, Aftab, Carmen Stanca, Andrea D. Branch, et al.. (2006). Increased prevalence of primary biliary cirrhosis near superfund toxic waste sites. Hepatology. 43(3). 525–531. 171 indexed citations
15.
Sigal, Samuel H., Carmen Stanca, Nickolas Kontorinis, Carol Bodian, & Elizabeth Ryan. (2006). Diabetes Mellitus Is Associated with Hepatic Encephalopathy in Patients with HCV Cirrhosis. The American Journal of Gastroenterology. 101(7). 1490–1496. 54 indexed citations
16.
Stanca, Carmen, Nancy Bach, Nidhi Tandon, et al.. (2005). Evaluation of Fatigue in U.S. Patients with Primary Biliary Cirrhosis. The American Journal of Gastroenterology. 100(5). 1104–1109. 44 indexed citations
17.
Stanca, Carmen, Maria Isabel Fiel, Jorge Allina, Cynthia Caracta, & Joseph A. Odin. (2005). Liver Failure in an Antimitochondrial Antibody-Positive Patient with Sarcoidosis: Primary Biliary Cirrhosis or Hepatic Sarcoidosis?. Seminars in Liver Disease. 25(3). 364–370. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026